- Clozapine in the Time of COVID-19
-
Boland X, Dratcu L
- KMID: 2505679
- Clin Psychopharmacol Neurosci.
- 2020 Aug;18(3):450-453.
- doi: 10.9758/cpn.2020.18.3.450
Clozapine is the most effective antipsychotic for treatment resistant schizophrenia but adverse reactions to clozapine include neutropenia. The current COVID-19 pandemic may raise specific concerns for clinicians prescribing clozapine for... -
- CITED
-
- Close
- SHARE
-
- Close
- Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
-
Montgomery A, Rogowska M, Dratcu L
- KMID: 2539665
- Clin Psychopharmacol Neurosci.
- 2023 Feb;21(1):202-206.
- doi: 10.9758/cpn.2023.21.1.202
Treatment-resistant schizophrenia (TRS) poses a significant therapeutic challenge in psychiatric practice. Clozapine is recognized as a treatment of choice in TRS but is not always effective in alleviating patients’ symptoms.... -
- CITED
-
- Close
- SHARE
-
- Close
